Francesc Artigas

18.9k total citations · 2 hit papers
276 papers, 14.5k citations indexed

About

Francesc Artigas is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Francesc Artigas has authored 276 papers receiving a total of 14.5k indexed citations (citations by other indexed papers that have themselves been cited), including 214 papers in Cellular and Molecular Neuroscience, 91 papers in Molecular Biology and 79 papers in Pharmacology. Recurrent topics in Francesc Artigas's work include Neurotransmitter Receptor Influence on Behavior (173 papers), Neuroscience and Neuropharmacology Research (127 papers) and Treatment of Major Depression (74 papers). Francesc Artigas is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (173 papers), Neuroscience and Neuropharmacology Research (127 papers) and Treatment of Major Depression (74 papers). Francesc Artigas collaborates with scholars based in Spain, United States and France. Francesc Artigas's co-authors include Pau Celada, Albert Adell, Analı́a Bortolozzi, M. Victoria Puig, N. Bel, Luz Romero, Noemí Santana, Guadalupe Mengod, Enric Álvarez and Mercè Amargós‐Bosch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Francesc Artigas

276 papers receiving 14.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists

1996 554 citations Francesc Artigas, Luz Romero et al. profile →
Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data

2014 400 citations Connie Sánchez, Francesc Artigas et al. Pharmacology & Therapeutics profile →

Peers

Countries citing papers authored by Francesc Artigas

Since Specialization

Citations

This map shows the geographic impact of Francesc Artigas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesc Artigas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesc Artigas more than expected).

Fields of papers citing papers by Francesc Artigas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesc Artigas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesc Artigas. The network helps show where Francesc Artigas may publish in the future.

Co-authorship network of co-authors of Francesc Artigas

This figure shows the co-authorship network connecting the top 25 collaborators of Francesc Artigas. A scholar is included among the top collaborators of Francesc Artigas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesc Artigas. Francesc Artigas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Scn1a haploinsufficiency in the prefrontal cortex leads to cognitive impairment and depressive phenotype 2024 ·Brain ·Maurizio S. Riga, (unknown), (unknown), Verónica Paz, Leticia Campa, Magdalena Martínez‐Losa, Francisco J. Esteban, Luís F. Callado, J. Javier Meana, Francesc Artigas, Analı́a Bortolozzi, Manuel Álvarez‐Dolado	7
2	iPSC ‐based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation 2023 ·EMBO Molecular Medicine ·(unknown), Irene Fernández‐Carasa, Carles Calatayud, (unknown), Meritxell Pons‐Espinal, (unknown), Leticia Campa, Francesc Artigas, Analı́a Bortolozzi, Rosario Domingo‐Jiménez, (unknown), Mercè Pineda, Rafael Artuch, Ángel Raya, Àngels García‐Cazorla, Antonella Consiglio	8
3	Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy 2022 ·Translational Psychiatry ·(unknown), (unknown), (unknown), Valentín Cóppola-Segovia, (unknown), Verónica Paz, Esther Ruiz‐Bronchal, Leticia Campa, Carmen Casal, Andrés Montefeltro, Miquel Vila, Francesc Artigas, (unknown), Analı́a Bortolozzi	36
4	Brain circuitry in major depressive disorder: The critical role of ventral anterior cingulate cortex 2021 ·European Neuropsychopharmacology ·Francesc Artigas	3
5	Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson's disease 2021 ·Pharmacology & Therapeutics ·Analı́a Bortolozzi, (unknown), Alon Chen, Francesc Artigas	30
6	Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine 2020 ·Translational Psychiatry ·(unknown), (unknown), Leticia Campa, Francesc Artigas, Anna Castañé	19
7	M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington’s disease 2020 ·eLife ·Sara Fernández‐García, (unknown), Esther García-García, Clara Gort‐Paniello, David Bernal‐Casas, Gerardo Garcia-Díaz Barriga, Xavier López-Gil, Emma Muñoz‐Moreno, Guadalupe Sòria, Leticia Campa, Francesc Artigas, Manuel J. Rodrı́guez, Jordi Alberch, Mercè Masana	29
8	Regionally selective knockdown of astroglial glutamate transporters in infralimbic cortex induces a depressive phenotype in mice 2019 ·Glia ·(unknown), Esther Ruiz‐Bronchal, Albert Ferrés‐Coy, (unknown), Francesc Artigas, Analı́a Bortolozzi	49
9	Astrocyte control of glutamatergic activity: Downstream effects on serotonergic function and emotional behavior 2019 ·Neuropharmacology ·(unknown), Júlia Gasull-Camós, (unknown), Anna Castañé, Analı́a Bortolozzi, Francesc Artigas	45
10	Subchronic vortioxetine treatment –but not escitalopram– enhances pyramidal neuron activity in the rat prefrontal cortex 2016 ·Neuropharmacology ·Maurizio S. Riga, Vicent Teruel‐Martí, Connie Sánchez, Pau Celada, Francesc Artigas	26
11	Therapeutic Potential of Conjugated siRNAs for the Treatment of Major Depressive Disorder 2016 ·Neuropsychopharmacology ·Francesc Artigas, Analı́a Bortolozzi	8
12	Poster Session I 2013 ·Neuropsychopharmacology ·Francesc Artigas, Maurizio S. Riga, Pau Celada, Connie Sánchez	2
13	Future Directions for Serotonin and Antidepressants 2013 ·ACS Chemical Neuroscience ·Francesc Artigas	44
14	Serotonin modulation of cortical neurons and networks 2013 ·SHILAP Revista de lepidopterología ·Pau Celada, M. Victoria Puig, Francesc Artigas	304
15	Catecholamine/Serotonin Interactions 2013 ·Advances in pharmacology ·Julie G. Hensler, Francesc Artigas, Analı́a Bortolozzi, Lynette C. Daws, Philippe De Deurwaerdère, (unknown), Sylvia Navailles, Wouter Koek	58
16	A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder 2011 ·The International Journal of Neuropsychopharmacology ·Enric Álvarez, Víctor Pérez, Marianne Dragheim, Henrik Loft, Francesc Artigas	180
17	The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. 2004 ·PubMed ·Pau Celada, M. Victoria Puig, Mercè Amargós‐Bosch, Albert Adell, Francesc Artigas	397
18	How does pindolol improve antidepressant action? 2001 ·Trends in Pharmacological Sciences ·Francesc Artigas, Pau Celada, Marc Laruelle, Albert Adell	145
19	Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression 1999 ·Biological Psychiatry ·(unknown), Víctor Pérez, (unknown), Enric Álvarez, Francesc Artigas	34
20	Preferential Potentiation of the Effects of Serotonin Uptake Inhibitors by 5‐HT_1A Receptor Antagonists in the Dorsal Raphe Pathway: Role of Somatodendritic Autoreceptors 1997 ·Journal of Neurochemistry ·Luz Romero, Francesc Artigas	138

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact